HappeningToo topic
Cabozantinib reports
Browse community reports connected to Cabozantinib. These reports can show that other people are describing similar experiences, but they do not prove that Cabozantinib caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
38 problems
Abdominal Discomfort while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and abdominal discomfort appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and abdominal pain upper appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and abdominal pain appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Acid reflux while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and acid reflux appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Acne while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and acne appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and alopecia appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and back pain appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and constipation appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and cough appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and decreased appetite appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dehydration while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and dehydration appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and diarrhea appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and dizziness appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dry Mouth while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and dry mouth appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dry Skin while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and dry skin appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dyspepsia while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and dyspepsia appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and fatigue appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and feeling abnormal appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Flatulence while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and flatulence appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and headache appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and insomnia appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and itching appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and malaise appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and muscle spasms appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Myalgia while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and myalgia appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and nausea appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Oral Discomfort while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and oral discomfort appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Oropharyngeal Pain while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and oropharyngeal pain appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and pain appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and rash appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and shortness of breath appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Skin redness while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and skin redness appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleepiness while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and sleepiness appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Taste changes while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and taste changes appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tingling or pins and needles while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and tingling or pins and needles appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and vomiting appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and weakness appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Cabozantinib
FDA FAERS contains adverse-event reports in which Cabozantinib and weight decreased appear together. This does not establish that Cabozantinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →